Normal or reactive minor cell populations in bone marrow and peripheral blood mimic minimal residual leukemia by flow cytometry.

Cytometry. Part B, Clinical Cytometry
Weijie LiAtif A Ahmed

Abstract

Measurable residual disease (MRD) is a strong independent poor prognostic factor for acute leukemia. Multiparameter flow cytometry (FCM) is a commonly used MRD detection method. However, FCM MRD detection is not well standardized, and the interpretation is subjective. There are normal/reactive minor cell populations in bone marrow (BM) and peripheral blood (PB), which could be confused with MRD. The FCM data of 231 BM and 44 PB pediatric samples performed in a recent 15-month period were retrospectively reviewed. These samples were from 56 B-lymphoblastic leukemia (B-ALL) patients, 11 T-lymphoblastic leukemia (T-ALL) patients, 28 acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS) patients, 44 cytopenia/leukocytosis patients, and five patients with mycosis fungoides. There were over 10 normal or reactive minor cell populations identified with certain phenotypes mimicking MRD of acute leukemia. These mimickers included CD19+ NK cells, CD22+ basophils, CD22+ dendritic cells (DCs), and plasma cells for B-ALL MRD; CD4/8 double-negative T cells, CD4/8 double-positive T cells, cytoplasmic CD3+ NK cells, CD2- T cells, CD7- T cells, CD5- gamma delta T cells, CD56+ NKT cells for T-ALL MRD; CD33+ NK cells, CD117+ NK cells, basoph...Continue Reading

References

Aug 26, 1998·Leukemia & Lymphoma·L EscribanoJ F San Miguel
Sep 10, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Matthew J Loza, Bice Perussia
Jun 20, 2007·Leukemia Research·Michael R LokenDenise A Wells
May 10, 2008·Archives of Pathology & Laboratory Medicine·Xiaohong HanWeina Chen
Nov 4, 2008·Archives of Pathology & Laboratory Medicine·Anja C RodenCurtis A Hanson
May 8, 2013·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Elisa MontaldoLorenzo Moretta
Nov 9, 2014·Journal of Leukocyte Biology·Cristina TeodosioAlberto Orfao
Apr 25, 2015·Cytometry. Part B, Clinical Cytometry·Brent L Wood
Jan 10, 2018·Immunology·Matthew Collin, Venetia Bigley
Dec 26, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Anouk A J HamersCatherine C Hedrick
May 1, 2019·Annals of Laboratory Medicine·Min Seung ParkDuck Cho

❮ Previous
Next ❯

Citations

Sep 19, 2021·Cytometry. Part B, Clinical Cytometry·Marie C Béné

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Basophils

Basophils are myeloid cells with a high affinity IgE receptor and is involved in inflammatory responses during allergy. Discover the latest research on Basophils here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.